Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake.

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
28 Feb 2021
Historique:
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 4 3 2021
Statut: epublish

Résumé

Racial and ethnic minorities have been disproportionately impacted by COVID-19. In the initial phase of population-based vaccination in the United States (U.S.) and United Kingdom (U.K.), vaccine hesitancy and limited access may result in disparities in uptake. We performed a cohort study among U.S. and U.K. participants in the smartphone-based COVID Symptom Study (March 24, 2020-February 16, 2021). We used logistic regression to estimate odds ratios (ORs) of COVID-19 vaccine hesitancy (unsure/not willing) and receipt. In the U.S. ( COVID-19 vaccine hesitancy was greater among racial and ethnic minorities, and Black participants living in the U.S. were less likely to receive a vaccine than White participants. Lower uptake among Black participants in the U.S. during the initial vaccine rollout is attributable to both hesitancy and disparities in access.

Sections du résumé

BACKGROUND BACKGROUND
Racial and ethnic minorities have been disproportionately impacted by COVID-19. In the initial phase of population-based vaccination in the United States (U.S.) and United Kingdom (U.K.), vaccine hesitancy and limited access may result in disparities in uptake.
METHODS METHODS
We performed a cohort study among U.S. and U.K. participants in the smartphone-based COVID Symptom Study (March 24, 2020-February 16, 2021). We used logistic regression to estimate odds ratios (ORs) of COVID-19 vaccine hesitancy (unsure/not willing) and receipt.
RESULTS RESULTS
In the U.S. (
CONCLUSIONS CONCLUSIONS
COVID-19 vaccine hesitancy was greater among racial and ethnic minorities, and Black participants living in the U.S. were less likely to receive a vaccine than White participants. Lower uptake among Black participants in the U.S. during the initial vaccine rollout is attributable to both hesitancy and disparities in access.

Identifiants

DOI: 10.1101/2021.02.25.21252402 PMID: 33655271 PMC: PMC7924296
pubmed: 33655271
doi: 10.1101/2021.02.25.21252402
pmc: PMC7924296
pii:
doi:

Types de publication

Preprint

Langues

eng

Commentaires et corrections

Type : UpdateIn

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
J Public Health (Oxf). 2020 Oct 30;:
pubmed: 33124667
Nature. 2018 May;557(7704):157-159
pubmed: 29743700
Ann Intern Med. 2020 Dec 1;:
pubmed: 33253040
JAMA. 2020 Sep 8;324(10):931-932
pubmed: 32766736
J Gen Intern Med. 2020 Oct;35(10):3097-3099
pubmed: 32754782
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
JAMA Intern Med. 2021 Jan 1;181(1):131-134
pubmed: 32804192
Science. 2020 Jun 19;368(6497):1362-1367
pubmed: 32371477
Nat Hum Behav. 2021 Feb 5;:
pubmed: 33547453

Auteurs

Long H Nguyen (LH)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Amit D Joshi (AD)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

David A Drew (DA)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Jordi Merino (J)

Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard. Cambridge, MA, USA.

Wenjie Ma (W)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Chun-Han Lo (CH)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Sohee Kwon (S)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Kai Wang (K)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Mark S Graham (MS)

School of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.

Lorenzo Polidori (L)

Zoe Global Ltd, London, U.K.

Cristina Menni (C)

Department of Twin Research and Genetic Epidemiology, King's College London, London, U.K.

Carole H Sudre (CH)

School of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.

Adjoa Anyane-Yeboa (A)

Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Christina M Astley (CM)

Broad Institute of MIT and Harvard. Cambridge, MA, USA.
Computational Epidemiology Lab and Division of Endocrinology, Boston Children's Hospital and Harvard Medical School. Boston, MA, USA.

Erica T Warner (ET)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Christina Y Hu (CY)

Zoe Global Ltd, London, U.K.

Somesh Selvachandran (S)

Zoe Global Ltd, London, U.K.

Richard Davies (R)

Zoe Global Ltd, London, U.K.

Denis Nash (D)

Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.

Paul W Franks (PW)

Department of Clinical Sciences, Lund University, Malmö, Sweden.

Jonathan Wolf (J)

Zoe Global Ltd, London, U.K.

Sebastien Ourselin (S)

School of Biomedical Engineering & Imaging Sciences, King's College London. London, U.K.

Claire J Steves (CJ)

Department of Twin Research and Genetic Epidemiology, King's College London, London, U.K.

Tim D Spector (TD)

Department of Twin Research and Genetic Epidemiology, King's College London, London, U.K.

Andrew T Chan (AT)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health. Boston, MA, USA.
Massachusetts Consortium on Pathogen Readiness, Cambridge, MA, USA.

Classifications MeSH